US Broker Ratings

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 63.7% Potential Upside in the Medical Devices Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) is capturing investor attention with a compelling growth narrative and a notable potential upside of 63.7% based on analyst consensus. As a key player in..

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Powerhouse with 46% Upside Potential

For investors with a keen eye on the biotechnology sector, Zai Lab Limited (NASDAQ: ZLAB) presents an intriguing opportunity. Based in China, this biopharmaceutical company is making significant strides in..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a 13% Potential Upside Amidst Healthcare Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the medical instruments and supplies industry, is attracting investor attention with its mix of challenges and potential. The company, with a market..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 23% Upside in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) stands out in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $2.42 billion, GeneDx has captured investor attention..

Kymera Therapeutics (KYMR) Stock Analysis: A 36% Upside Potential Ignites Investor Interest

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a pioneering name in the biotechnology sector, has caught the attention of investors with its ambitious approach to drug discovery and development. The company, headquartered..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 42% Potential Upside in Innovative Dermatology Solutions

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is arguably an intriguing player within the biotechnology sector, especially for investors eyeing compelling growth opportunities in healthcare. With a focus on dermatological diseases, Arcutis..

Agios Pharmaceuticals (AGIO): Investor Outlook with a 34% Potential Upside and Strong Buy Ratings

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands out in the competitive biotechnology sector with its innovative approach to cellular metabolism. Headquartered in Cambridge, Massachusetts, Agios has carved a niche for itself..

Belite Bio (BLTE) Stock Analysis: Exploring the 51% Upside Potential in Biotech

Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to treating retinal degenerative diseases. With a market capitalization of..

Ascentage Pharma Group Internat (AAPG): Revenue Growth Soars Despite Market Challenges

Ascentage Pharma Group International (AAPG), a Chinese biotechnology firm, is making significant strides in the healthcare sector with an impressive 97.90% growth in revenue. Specializing in the development of therapies..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 37.5% Potential Upside Awaits

Scholar Rock Holding Corporation (NASDAQ: SRRK) is rapidly gaining attention in the biotechnology sector with its pioneering approach to targeting protein growth factors for treating serious diseases. Based in Cambridge,..

Sotera Health Company (SHC) Stock Analysis: Unlocking an 18.66% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC), a significant player in the healthcare sector’s diagnostics and research industry, presents an intriguing investment opportunity with a potential upside of 18.66%. With a market..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 40.82% Potential Upside

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specializes in medical devices that cater to neurological and cardiac conditions. With a market capitalization of $2.37 billion, the..

Addus HomeCare Corporation (ADUS) Stock Analysis: Strong Buy Ratings Suggest 25% Upside Potential

Investors seeking opportunities in the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing option. With a current market capitalization of $2.01 billion, Addus stands out as a..

Harmony Biosciences Holdings, I (HRMY): Investor Outlook Reveals 40% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector, standing out with a market cap of $2.05 billion and a targeted focus on developing therapies for..

Certara, Inc. (CERT) Stock Analysis: Unlocking a 37.51% Upside Potential in a Transformative Healthcare Sector

Certara, Inc. (NASDAQ: CERT) represents a compelling opportunity for investors interested in the convergence of healthcare and technology. With its comprehensive suite of software solutions and services aimed at enhancing..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 40% Potential Upside

Vericel Corporation (NASDAQ: VCEL) is making waves in the biotechnology sector, driving curiosity among investors seeking opportunities in the healthcare industry. With a market capitalization of $2.09 billion, Vericel is..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring a Potential 132% Upside in the Biotech Sector

For individual investors eyeing the dynamic biotech sector, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) presents an intriguing opportunity. With a current market cap of $2.84 billion, this San Diego-based company is..

NewAmsterdam Pharma (NAMS): Investor Outlook on a Biotech with 77% Potential Upside

NewAmsterdam Pharma Company N.V. (NAMS), a Netherlands-based biopharmaceutical firm, is capturing the attention of investors with its promising pipeline in the biotechnology sector. Specializing in the development of therapies for..

ImmunityBio, Inc. (IBRX) Investor Outlook: Exploring a 330% Potential Upside in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to cancer and infectious disease therapies. Based in San Diego, California,..

Perrigo Company plc (PRGO) Investor Outlook: A 29.75% Upside Potential Amidst Healthcare Sector Challenges

Perrigo Company plc (PRGO), a stalwart in the healthcare sector, is making headlines with its potential for a substantial 29.75% upside, a figure that has caught the attention of individual..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds